NCT06744530

Cardiac RadiothErapy for VEntricular Tachycardia II

Cardiac RadiothErapy for VEntricular Tachycardia II - a Prospective Observational Cohort Study

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Universitaire Ziekenhuizen KU Leuven · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.

Conditions

• Ventricular Tachycardia (VT)

Interventions

Type	Name	Description
PROCEDURE	stereotactic radiotherapy ablation	Single dose of 25 Gy up to 32.5 Gy on the myocardium in patients with therapy-refractory ventricular tachycardia

Timeline

• Start date: 2025-01-01
• Primary completion: 2033-12-01
• Completion: 2034-12-01
• First posted: 2024-12-20
• Last updated: 2025-01-07

Locations

1 site across 1 country: Belgium